Transcriptional cascades are required for the specification of serotonin (5-HT) neurons and behaviors modulated by 5-HT. Several cascade factors are expressed throughout the lifespan, which suggests that their control of behavior might not be temporally restricted to programming normal numbers of 5-HT neurons. We used new mouse conditional targeting approaches to investigate the ongoing requirements for Pet-1 (also called Fev), a cascade factor that is required for the initiation of 5-HT synthesis, but whose expression persists into adulthood. We found that Pet-1 was required after the generation of 5-HT neurons for multiple steps in 5-HT neuron maturation, including axonal innervation of the somatosensory cortex, expression of appropriate firing properties, and the expression of the Htr1a and Htr1b autoreceptors. Pet-1 was still required in adult 5-HT neurons to preserve normal anxiety-related behaviors through direct autoregulated control of serotonergic gene expression. These findings indicate that Pet-1 is required across the lifespan of the mouse and that behavioral pathogenesis can result from both developmental and adult-onset alterations in serotonergic transcription.
a r t I C l e S The 5-HT transmitter system in the brain is an essential homeostatic modulator of neural circuits that shape emotional behaviors in response to stressors in the environment 1 . A widely discussed theory supported by a rich literature emphasizes the importance of 5-HT function for the maturation of neural circuits and the development of normal adult emotional behaviors 2 . Altered serotonergic signaling and gene expression during embryonic development disrupts cortical dendritic arborization 3 and the patterning of forebrain afferents 4, 5 . Other studies show that early postnatal perturbation of the serotonergic system can cause emotional disorders in adult animals [6] [7] [8] . These findings, together with correlative studies of serotonergic indices and gene variants in monkeys and humans, support the idea that alterations in serotonergic function are involved in establishing vulnerability for several mood and neurological disorders 1,9 . The likelihood that altered serotonergic function during development contributes to behavioral pathogenesis has stimulated interest in the genetic mechanisms that direct the formation of the 5-HT system 10 . A cascade (Supplementary Fig. 1 ) of transcriptional regulators has been identified that progressively restricts multi-potent neuronal progenitors to a 5-HT neuron fate in the embryonic ventral hindbrain 11 . Genetic targeting of factors in the cascade causes alterations in 5-HT-modulated emotional responses in adults 12, 13 , and this finding provides a link between the transcriptional regulation of 5-HT neuron birth and adult behavior. Nevertheless, the mechanisms through which transcription factors in the cascade regulate behavior are poorly understood and might not be simply the result of programming normal 5-HT neuron numbers and 5-HT levels. For example, although all of the factors known to compose the cascade are necessary for the initiation of 5-HT synthesis at the cell fate specification stage, transcriptional control of subsequent steps in the maturation of the 5-HT system might also be crucial for programming normal 5-HT-modulated behaviors. However, whether or not factors in the cascade are responsible for additional transcriptional events in the maturation of the system has not been investigated. Furthermore, it is not known whether the critical period for transcription directed by these developmental determinants extends into adulthood to regulate the maintenance of 5-HT signaling and preserve behavioral integrity. The concept of a transcriptional maintenance mechanism could be crucial for understanding the regulation of behavioral and psychiatric pathogenesis as drug, toxin and dietary perturbation studies in adults including humans demonstrate the importance of ongoing presynaptic serotonergic function in emotional and behavioral processing 9 .
Expression of the rodent Pet-1 ETS domain transcription factor (human orthologue, FEV) is restricted in the CNS to 5-HT neurons and is induced in postmitotic precursors just before the initiation of 5-HT synthesis in the ventral hindbrain 14 . Pet-1 has a crucial role in the cascade through its coordinate induction of the enzymatic pathway responsible for 5-HT synthesis in immature postmitotic precursors 12 . Interestingly, Pet-1 expression seems to continue undiminished in all adult 5-HT neurons 14 . This persistent expression suggests that Pet-1 might be required for events in 5-HT neuron maturation that occur subsequent to their specification and possibly in adulthood for transcriptional maintenance of the 5-HT system. Here, we used new 5-HT neuron-specific and temporally restricted conditional targeting approaches to investigate requirements for continued Pet-1-dependent transcription in the 5-HT system.
RESULTS

Conditional deletion of Pet-1 after 5-HT neuron generation
To investigate the function of Pet-1 after its initial role in 5-HT neuron generation, we inserted two loxP sites into introns on each side of exon 3, which encodes most of the Pet-1 protein coding sequences including the ETS DNA-binding domain (Fig. 1) . In situ hybridization ( Fig. 1b,c) and quantitative reverse transcriptase PCR (RT-qPCR; Supplementary Fig. 2 ) indicated that Pet-1 expression was indistinguishable in mice carrying either one copy of the wild-type or loxP-flanked Pet-1 allele together with a constitutive null allele. Excision of exon 3 generated a deleted Pet-1 allele (Δ) in which all protein coding sequences except those encoding 42 amino acids at the N terminus were eliminated ( Fig. 1a) . In situ hybridization showed that Pet-1 was not expressed in mice heterozygous for the deleted and null Pet-1 alleles ( Fig. 1d ). Furthermore, Pet-1 loxP/− mice had normal numbers of tryptophan hydroxylase (Tph)-positive neurons but Pet-1 Δ/− mice did not ( Supplementary Fig. 2) . Thus, the unrecombined loxP-flanked allele is functionally equivalent to the wild-type allele and the conditionally deleted Pet-1 allele is functionally equivalent to the constitutive null Pet-1 allele.
We crossed loxP-flanked Pet-1 mice with ePet::Cre transgenic mice 15 , which express Cre recombinase only in postmitotic 5-HT neurons, to generate Pet-1 early conditional knockout mice (Pet-1 loxP/− ePet::Cre, designated Pet-1 eCKO ). Nearly all 5-HT neurons derived from progenitors in rhombomeres 1 and 2 are born by embryonic days (E)10 and 11, respectively 16, 17 . However, reduced serotonergic gene expression is not seen in mice carrying this ePet::Cre transgene until about E12. 5 (ref. 18) . Thus, Pet-1 expression should be maintained in Pet-1 eCKO mice for about 2 d after fulfilling its early role in 5-HT neuron generation ( Fig. 1e) . On the basis of this reasoning, we predicted that normal numbers of 5-HT neurons would be generated in Pet-1 eCKO mice.
Consistent with our expectation, we found that expression of Pet-1 and other 5-HT neuron markers including tryptophan hydroxylase 2 (Tph2), serotonin transporter (Slc6a4, also called Sert) and another transcription factor, Gata3, was indistinguishable between Pet-1 eCKO mice and wild-type controls in the anterior hindbrain at E11.5 (Fig. 1f,h and Supplementary Fig. 3 ). Furthermore, immunohistochemistry using antibodies to 5-HT showed that Pet-1 eCKO mice had the same number of 5-HT + neurons as did controls (Fig. 1j,k) . By contrast, Pet-1 −/− mice had very few 5-HT + cells at this stage ( Fig. 1l) . We did not observe a decrease in Pet-1 transcripts in Pet-1 eCKO mice until E12.5 (Fig. 1g) . Concomitant with the conditional deletion of Pet-1 at E12.5, the expression of Tph2, Slc6a4 and 5-HT in Pet-1 eCKO mice was diminished ( Supplementary Fig. 3 ), whereas the expression of Gata3 was not altered (Fig. 1i) . Pet-1 is not required for the survival of 5-HT neurons 19 , and all Pet-1-deficient cells were present in the brains of Pet-1 eCKO mice through adulthood ( Supplementary Fig. 4) .
These findings indicate that Pet-1 eCKO mice can be used to investigate Pet-1 function in 5-HT system maturation after it has fulfilled its initial role in 5-HT neuron generation.
Continued Pet-1 function controls serotonergic innervation Immediately after the birth of 5-HT neurons, maturation of the 5-HT system depends on proper cell body migration, axon pathfinding and innervation in terminal fields 20 . To investigate the role of Pet-1 in these maturation events, we used Cre-mediated activation of the R26R Yfp (ref. 21) reporter allele to permanently mark Pet-1-deficient 5-HT neurons in Pet-1 eCKO mice (Fig. 2) . Pet-1 deletion was spared in a small subset (~15%) of 5-HT neurons in Pet-1 eCKO mice (Supplementary Fig. 4 ) and therefore Pet-1-deficient Tph − cells were situated side by side with untargeted Tph + 5-HT neurons ( Fig. 2a) . Examination of R26R-Yfp + cells in Pet-1 eCKO mice showed that these Pet-1-deficient 5-HT neurons extended axons from their cell bodies, similar to intermingled wild-type Tph + cells, and therefore Pet-1 was not essential for proximal axonal outgrowth ( Fig. 2a) . Immunostaining for yellow fluorescent protein (YFP) in Pet-1 eCKO mice revealed that axon bundles from Pet-1-deficient 5-HT neurons crossed the midbrain-hindbrain boundary and entered the midbrain at E14.5 (Fig. 2b) .
To determine whether these axons could properly reach their forebrain targets, we performed a retrograde tracing experiment by injecting tracer into the somatosensory cortex, which receives serotonergic afferents mainly from 5-HT neurons in the dorsal raphe (DRN; Fig. 2c ). In 3-week-old wild-type and Pet-1 eCKO mice, such injection resulted in the retrograde labeling of both 5-HT and non-5-HT neurons in the DRN ( Fig. 2d-f ). The tracer intensity in Pet-1-deficient 5-HT neurons was comparable to that in other retrogradely labeled cells, suggesting that Pet-1-deficient cells could retrogradely transport tracer ( Fig. 2f) . We found a significant decrease in the total number of labeled cells across the entire DRN in Pet-1 eCKO mice ( Fig. 2g,h) . In wild-type mice, most retrogradely labeled cells were 5-HT neurons ( Fig. 2i,k) . In contrast, far fewer Pet-1-deficient YFP + 5-HT neurons were labeled by similar tracer injections ( Fig. 2j,l) , indicating that the serotonergic innervation of the somatosensory cortex from DRN 5-HT neurons was significantly disrupted in the brains of Pet-1 eCKO mice.
Continued Pet-1 function controls autoreceptor pathways
Another key event in the maturation of 5-HT neuron function in the brain is the acquisition of 5-HT neuron-specific firing properties 23 .
To study whether continued Pet-1 function is required for normal firing of 5-HT neurons, we analyzed Pet-1-deficient R26R-Yfp + cells in postnatal brain slices from Pet-1 eCKO mice by using whole-cell recordings under current-clamp conditions. Compared with the agedmatched controls, many Pet-1-deficient cells showed increased spontaneous firing of action potentials ( Fig. 3a-c) . This increased excitability could result from alterations in Htr1a autoreceptor signaling, which normally inhibits the firing of 5-HT neurons through negative feedback inhibition 24 . As previously described 25 , activation of the Htr1a receptor with its specific agonist a r t I C l e S 8-OH-DPAT elicited strong inwardly rectifying potassium currents in control YFP + 5-HT neurons under voltage clamp ( Fig. 3d ). By contrast, neither low (1 μM) nor high (10 μM) concentrations of 8-OH-DPAT elicited a change in baseline currents in Pet-1-deficient YFP + 5-HT neurons ( Fig. 3e,f) . To investigate the mechanism that accounts for the loss of 8-OH-DPAT responses, we used in situ hybridization to examine the expression of the Htr1a receptor and found greatly decreased levels of Htr1a mRNA in the Pet-1 eCKO DRN (Fig. 3g,h) .
A second prominent serotonergic autoreceptor that regulates 5-HT release in serotonergic presynaptic terminals is the Htr1b receptor 26 . In situ hybridization in Pet-1 eCKO mice revealed that Pet-1 was also required for expression of the Htr1b gene ( Fig. 3i,j) . The residual expression of Htr1a and Htr1b mRNAs is probably from the remaining untargeted 5-HT neurons in Pet-1 eCKO mice as the expression of the two autoreceptors in the DRN was almost completely abolished Fig. 5 ). Our in situ hybridization studies (data not shown) indicated that the expression of Htr1a and Htr1b in nearly all 5-HT neurons begins after E14, which is consistent with their onset in the forebrain at E14. 5 (ref. 27) . Thus, our findings show that ongoing Pet-1 expression is required, well after it has completed its role in the initiation of 5-HT synthesis in immature precursors, for maturation of essential serotonergic autoreceptor characteristics that control firing patterns and transmitter release.
Gata3 is not required for Htr1a autoreceptor responses
We investigated whether the establishment of normal 5-HT neuron firing properties requires parallel ongoing activity of other serotonergic developmental control genes, or whether Pet-1 has a unique role in this process. Germ line targeting of the zinc finger transcription factors Gata2 and Gata3 has shown that both are required for 5-HT neuron differentiation 28 . We found that Gata2 protein expression began to decline in differentiated 5-HT neurons at E12.5 and was not detectable at E14.5. By contrast, Gata3 expression persisted in all 5-HT neurons through adulthood (Supplementary Fig. 6) .
To compare the role of Gata3 in differentiated 5-HT neurons with that of Pet-1, we crossed Gata3 loxP/loxP mice 29 with ePet::Cre mice to generate Gata3 conditional knockout mice (Gata3 loxP/loxP ePet::Cre, designated as Gata3 eCKO ). Similar to Pet-1, Gata3 was not required for cell survival as normal numbers of Gata3-deficient 5-HT neurons survived in the adult brain ( Fig. 4) . However, there was a substantial reduction in the number of Tph immunoreactive cells ( Fig. 4b,d) , levels of 5-HT ( Fig. 4f,g) and expression of several other 5-HT genes ( Fig. 4e ) in the DRN of Gata3 eCKO mice. Persistent expression of Gata3 and Pet-1 seems to be maintained by independent regulatory pathways, as neither of them was required for the other's expression ( Figs. 1i and 4c) . These findings suggest that Gata3 and Pet-1 function in parallel pathways to coordinate the expression of normal levels of serotonergic gene expression and 5-HT in the brain.
Although Gata3 and Pet-1 share several common transcriptional targets, Gata3-deficient 5-HT neurons showed normal Htr1a expression ( Fig. 4e) , indicating that Pet-1 and Gata3 regulate distinct sets genes in 5-HT neurons. These findings also suggest that Gata3 might not be required for serotonergic firing characteristics. Indeed, whole-cell recordings of slices from Gata3 eCKO mice showed firing properties and Htr1a agonist responses typical of wild-type 5-HT neurons (Fig. 4h,i) .
Targeting of Pet-1 in the adult ascending 5-HT system Having shown that ongoing Pet-1 function is needed for multiple steps in the maturation of the 5-HT system, we sought to determine whether a Pet-1-dependent transcriptional program still operates in adulthood to support serotonergic function and 5-HT-modulated VOLUME 13 | NUMBER 10 | OCTOBER 2010 nature neurOSCIenCe a r t I C l e S behaviors (Fig. 5a) . Thus, we used Pet-1 regulatory elements to generate a transgene that directed tamoxifen-inducible CreER T2 (Cre recombinase-estrogen receptor ligand binding domain, ref. 30) expression specifically in brain 5-HT neurons. To identify founder lines expressing inducible Cre activity, we gave pregnant females a single dose of tamoxifen (150 μg per g, intraperitoneal) at gestational stage E11.5 and scored embryos for Creactivated β-galactosidase expression from the R26R βgal allele at E16.5 ( Supplementary  Fig. 7) . Eight-week-old Cre reporter mice (R26R βgal+ ePet::CreER T2 ) were then given a single daily dose of tamoxifen or vehicle for five consecutive days. Most 5-HT neurons in the DRN and median raphe nucleus (MRN) contained β-galactosidase 5 or 30 days after the last tamoxifen injection. Recombination was strictly dependent on tamoxifen treatment as we found no Cre activity in the absence of tamoxifen. We did not detect Cre activity in other regions of the CNS after tamoxifen injections (Supplementary Fig. 7) .
In one of the transgenic lines, designated ePet::CreER T2ascend , we found differential targeting efficacies after treatment of adult mice with tamoxifen between 5-HT neuron raphe nuclei that give rise to ascending and descending 5-HT systems (Fig. 5b,c) . Double-labeling to detect β-galactosidase and Tph revealed tamoxifen-activated Cre activity in up to 80% of 5-HT neurons in the DRN (B6, B7), MRN (B5, B8) and B9 nucleus. By contrast, far fewer 5-HT neurons contained β-galactosidase in the medullary nuclei (B1-B3) after tamoxifen treatment (Fig. 5d,e) .
To determine the efficacy of the ePet::CreER T2ascend line for excision of Pet-1 in Pet-1 loxP/− mice, we crossed ePet::CreER T2ascend , Pet-1 −/− and Pet-1 loxP/loxP mice to generate Pet-1 loxP/− ePet::CreER T2ascend mice, designated as Pet-1 aCKO . Six-to-eight-week-old Pet-1 aCKO mice were given single daily tamoxifen treatments for 5 d and killed 5 or 30 d after tamoxifen treatments for evaluation of Pet-1 expression. In situ hybridization showed that tamoxifen treatment abolished the majority of Pet-1 expression in the adult DRN (B6 and B7 nuclei), MRN (B5 and B8 nuclei) and the B9 group of 5-HT neurons (Fig. 5f,g) . By contrast, Pet-1 mRNA was not decreased in the B1-B3 groups of 5-HT neurons in the ventral medulla ( Fig. 5h,i) . The reduction of Pet-1 in Pet-1 aCKO mice treated with tamoxifen was further quantified by RT-qPCR, which revealed a >70% loss of Pet-1 mRNA in pontine tissue containing the B5-B9 serotonergic nuclei, but no significant change in tissue containing the medullary B1-B3 nuclei (Fig. 5j) . The loss of Pet-1 mRNA in the B5-B9 nuclei showed that ePet::CreER T2ascend could be used for highly reproducible and stage-specific disruption of Pet-1 expression in adult ascending 5-HT neurons.
Adult Pet-1 is required for normal anxiety-like behaviors Germ line targeting of Pet-1 results in increased anxiety-like behaviors in the adult. However, it remains unclear whether Pet-1-dependent transcription is needed only during development or also in adulthood to modulate normal anxiety responses. To address this question, we treated 6-8-weekold Pet-1 aCKO mice with tamoxifen to delete Pet-1 in the ascending 5-HT system. We then investigated the effect of adult Pet-1 deletion on anxietyrelated behaviors 4 weeks after the last tamoxifen treatment.
It was recently shown, using an administration protocol similar to that used here, that tamoxifen does not alter anxiety-related behaviors in mice 31 . We verified this finding on a separate cohort of wild-type mice treated with either vehicle or tamoxifen (Supplementary Fig. 8 ).
We then tested tamoxifen-treated control and Pet-1 aCKO mice on the elevated plus maze test and found that tamoxifen-treated Pet-1 aCKO mice spent significantly less time in and initiated fewer entries into the open unprotected arms of the maze than did tamoxifen-treated control mice (Fig. 6a,b) . In addition, these mice spent less time in the hub area but significantly more time in the closed arm ( Fig. 6c,d) . We found no differences between genotypes in overall explorative activities determined as the number of total open/closed arm entrances (Fig. 6e) . Their increased avoidance of the aversive properties of height and openness suggests that tamoxifen-treated Pet-1 aCKO mice show augmented anxiety-like behavior. To further study this behavior, we tested the same mice in the light↔dark exploration paradigm, which presents the mice with a similar conflict between the desire to explore a novel environment and the aversive features of a brightly illuminated open field. As compared to tamoxifen-treated littermate controls, tamoxifen-treated Pet-1 aCKO mice spent significantly more time in the dark chamber ( Fig. 6f,g) with a trend towards reduced latency to enter the dark area from the beginning of the test (Fig. 6h) . The increased time in the dark area and avoidance of the bright open areas supported the idea that tamoxifen-treated Pet-1 aCKO mice show increased anxiety-like behavior. Finally, tamoxifen-treated Pet-1 aCKO mice spent significantly less time than controls in the center of an open field (Fig. 6i) , whereas overall locomotor activity (Fig. 6j) . A second, independent cohort mice showed similar significant increases in all three tests of anxiety-like behaviors in tamoxifen-treated Pet-1 aCKO mice ( Supplementary  Fig. 9 ). Furthermore, the increased anxiety-like behavior seen in all three tests depended on reduced Pet-1 levels, as we found no differences in a separate cohort of Pet-1 aCKO mice treated with vehicle ( Supplementary Fig. 10 ). Overall growth measured by body weight was similar in control and Pet-1 aCKO mice after tamoxifen treatments (data not shown).
Adult Pet-1 is required for serotonergic gene expression
The altered anxiety-like behaviors in tamoxifen-treated Pet-1 aCKO mice show that Pet-1 is required in adulthood to maintain serotonergic function. To explore the mechanisms that underlie the alterations in serotonergic function, we first measured levels of brain 5-HT and its metabolite 5-HIAA in Pet-1 aCKO and control mice killed 5 days after tamoxifen treatments. High-performance liquid chromatography (HPLC) analysis showed that both 5-HT and 5-HIAA were significantly decreased in the forebrain of tamoxifen-treated Pet-1 aCKO mice (Fig. 7a,b) , but, as predicted, 5-HT levels were not altered in the spinal cord (data not shown), which is innervated by the descending 5-HT system. Western blotting using a monoclonal antibody to both Tph1 and Tph2 indicated that levels of Tph were reduced by about 50% in tamoxifen-treated Pet-1 aCKO mice relative to controls (Fig. 7c,d) . Consistent with these findings, we found a comparable decrease in Tph2 mRNA levels in tamoxifen-treated Pet-1 aCKO mice as early as 5 d after the last tamoxifen treatment (Fig. 7e,f) . Furthermore, Tph2 mRNA was still decreased 30 d after the last treatment and we did not find a compensatory increase in Tph1 expression with the loss of Tph2 (Fig. 7e) . Together, these findings indicate that Pet-1 is required in adult 5-HT neurons to regulate 5-HT synthesis by maintaining Tph2 expression.
To determine whether disruption of the Htr1a autoreceptor pathway might have contributed to the abnormal anxiety-like behavior, we performed whole-cell recordings in slices from tamoxifen-treated Pet-1 aCKO mice but found that Pet-1 was no longer required in the adult brain for spontaneous firing, autoreceptor agonist responses a r t I C l e S ( Fig. 7j,k) , or Htr1a gene expression ( Fig. 7e) . To explore other potential deficits beyond the loss of 5-HT, we analyzed the set of additional genes that are known to depend on Pet-1 in the embryonic hindbrain as well as other genes that are important for 5-HT synthesis and metabolism (Fig. 7e,f-i) . The expression of Slc6a4 and vesicular glutamate transporter 3 (Slc17a8, also called Vglut3) were also significantly reduced (Fig. 7e,h) , but for Slc17a8, decreased expression was not observed until 30 d after tamoxifen treatments (Fig. 7e) .
In contrast to the marked decreases in Tph2, Slc6a4 and Slc17a8 expression, Pet-1 was no longer required in adulthood to maintain the expression of Ddc (also called Aadc and Maob) and Slc18a2 (also called Vmat2) mRNA (Fig. 7e) , even though their embryonic expression depends on Pet-1 function (Supplementary Figure 3) .
Direct autoregulation of serotonergic gene expression
The studies presented so far do not distinguish direct from indirect transcriptional control of target genes by Pet-1. We previously identified a consensus Pet-1-binding sequence, GGAAR(T), upstream of Slc6a4 and showed that Pet-1 protein interacted with this site in vitro 14 . Further analyses identified conserved putative Pet-1 ETS binding sites in highly conserved upstream regulatory regions of Tph2 and Slc6a4 genes ( Supplementary Fig. 11 ). To probe the mechanism through which Pet-1 regulates Tph2 and Slc6a4 in 5-HT neurons, we investigated the possibility that Pet-1 directly regulates their transcription by interacting with conserved upstream regulatory elements. Because we have been unable to prepare a suitable Pet-1 antibody for chromatin immunoprecipitation (ChIP), we generated a new transgenic mouse line that expressed a myc-epitope-tagged Pet-1 protein in the brains of Pet-1 −/− mice with Pet-1 promoter/enhancer sequences 15 . Expression of the ePet::mycPet-1 transgene recapitulated endogenous Pet-1 expression in both developing and adult hindbrain, resulting in the rescue of normal numbers of 5-HT neurons in Pet-1 −/− mice (Supplementary Fig. 12 ). We used this rescue line for ChIP to determine whether Pet-1 directly interacted with Tph2 and Slc6a4 promoter sequences in vivo. Chromatin was harvested from E12.5 mouse hindbrain before extensive 5-HT neuron dispersion began to scatter these cells, although the dissected tissue was still largely composed of non-serotonergic cells. Sheared chromatin was immunoprecipitated with an anti-myc antibody and analyzed by RT-qPCR for anti-myc enrichment of genomic fragments that included predicted Pet-1-binding sites upstream of Tph2 and Slc6a4 as well as in the intron of Slc6a4 (+11390). Compared to the control, we found no enrichment near the Slc6a4 intron sequence. By contrast, upstream Tph2 and Slc6a4 sequences showed several-fold enrichment compared to both the negative control region untr17 and the Slc6a4 intron sequence in two independent immunoprecipitation assays ( Fig. 7l and data not shown) .
Finally, we used the ePet::CreER T2ascend transgene as a reporter for Pet-1-dependent regulation of its own enhancer in Pet-1 aCKO mice. Expression of CreER T2 in the adult DRN was significantly reduced in Pet-1 aCKO mice treated with tamoxifen, but not in Pet-1 aCKO mice treated with vehicle, showing that adult expression of Pet-1 depends on positive autoregulation (Fig. 7m,n) . Inspection of the upstream Pet-1 promoter/enhancer sequences 32 revealed conserved Pet-1 consensus binding sites at −465 and −621 relative to the predicted transcription start site (Supplementary Fig. 11 ). ChIP for genomic fragments with these binding sites revealed a tenfold enrichment relative to control immunoprecipitations ( Fig. 7l and data not shown) . These findings suggest that transcriptional regulation of 5-HT synthesis and serotonergic gene expression in adulthood depends on direct positive autoregulatory maintenance of Pet-1 expression.
DISCUSSION
In this study, we tested the idea that Pet-1, a key component of an embryonic transcriptional cascade that generates 5-HT neurons in the ventral hindbrain, continues to regulate subsequent milestones in 5-HT system maturation and 5-HT function in adulthood. We have shown that Pet-1 function is not restricted to the induction of serotonergic characteristics in embryonic 5-HT neuron precursors. Instead, ongoing Pet-1-directed transcription is required across the lifespan for multiple regulatory events that shape and maintain the serotonergic neurotransmitter system. Our findings also support the idea that the etiology of behavioral pathogenesis is not limited to dysfunction of the serotonergic system during development but may also result from adult-onset alterations in serotonergic transcription.
These and earlier findings 12 define three general but distinct stages of Pet-1 function. The initial stage occurs during serotonergic neurogenesis, when Pet-1 regulates a late phase of 5-HT neuron generation by coordinating the induction of key serotonergic genes that are required for transmitter synthesis, reuptake and vesicular transport in immature postmitotic precursors 12 . Here, we uncovered a second stage of Pet-1 function using a conditional targeting approach that did not interfere with Pet-1 expression until about 2 d after the completion of serotonergic neurogenesis. This transcriptional stage coincides with the prolonged period of 5-HT neuron maturation, during which these cells must negotiate complex axonal growth and pathfinding decisions and acquire their characteristic firing properties. We identified multiple requirements for Pet-1 at this second stage, which showed that Pet-1 is essential for proper 5-HT system maturation. For example, retrograde tracing of R26R-YFP-marked Pet-1-deficient 5-HT neurons revealed a substantial deficit in the number of serotonergic projections to the somatosensory cortex. However, initial serotonergic axon-like outgrowth did not appear to be compromised in Pet-1 eCKO mice, which suggests that Pet-1-dependent transcription regulates subsequent pathfinding decisions that help to build the ascending serotonergic system. The innervation defects in Pet-1 eCKO mice were probably not contributed to by the reduction in brain 5-HT. Although pharmacological disruption of embryonic 5-HT signaling alters neuronal organization in the presubicular cortex 33 and 5-HT regulates thalamocortical axon pathfinding by modulating axonal responsiveness to guidance cues 5 , recent studies of Tph2-targeted mice, which lack 5-HT synthesis in the brain, did not find defects in serotonergic innervation patterns 34 .
We also identified a special role for continued Pet-1-directed transcription, not shared by Gata3, in regulating the maturation of 5-HT neuron firing frequency through the control of 5-HT autoreceptormediated inhibitory responses. Similar to the innervation defects, the defects in firing frequencies and autoreceptor-mediated inhibitory responses were probably not caused simply by reduced 5-HT, as 5-HT is also reduced in the brains of Gata3 eCKO mice. Instead, our findings showed that Pet-1 transcriptionally controls spontaneous firing frequency and inhibitory responses by regulating expression of the Htr1a autoreceptor gene. In addition, Pet-1 was required for expression of the presynaptic Htr1b autoreceptor. Because Htr1a and Htr1b are not normally expressed until several days after 5-HT neuron generation, our findings support the hypothesis that persistent Pet-1directed transcription is essential for maturation steps during which 5-HT neurons acquire key functional characteristics.
We identified a third stage of Pet-1 function using a tamoxifeninducible targeting approach that resulted in a severe and selective reduction in Pet-1 in the adult ascending 5-HT system. Significantly, the targeting of Pet-1 in adult 5-HT neurons revealed that this late stage of Pet-1 function is required in the adult ascending 5-HT system a r t I C l e S to maintain emotional behaviors. Our finding that tamoxifen-treated Pet-1 aCKO mice showed altered emotional behavior was supported by three tests of rodent anxiety-related behavior performed on two independent cohorts of mice that were tested several months apart. The simplest interpretation of our findings is that the accompanying reduction in 5-HT levels in the ascending serotonergic system accounted for the elevated anxiety in tamoxifen-treated Pet-1 aCKO mice. However, the literature regarding the effect of neurotoxin-mediated depletion of 5-HT on anxiety in adult rats is conflicting, with both anxiogenic and anxiolytic effects being reported depending on experimental design [35] [36] [37] . Furthermore, as Pet-1 is likely to control a network of downstream transcriptional targets, the increased anxietylike behavior in tamoxifen-treated Pet-1 aCKO mice may have resulted from multiple alterations in adult serotonergic function. We found a reduction in Slc6a4 and Slc17a8 gene expression in these mice, which suggests that there were complex changes in the 5-HT neuron genetic network. A recent study showed that at least part of the ascending 5-HT system engages in dual serotonergic/glutamatergic fast synaptic transmission 38 . Reduced expression of Slc17a8 in tamoxifen-treated Pet-1 aCKO mice was not observed until 30 d after the tamoxifen treatments, indicating that adult loss of Pet-1 expression could have elicited gradual changes in glutamatergic transmission that contributed to the behavioral phenotype of tamoxifen-treated Pet-1 aCKO mice.
The normal expression of the Htr1a autoreceptor and Htr1amediated inhibitory responses in tamoxifen-treated Pet-1 aCKO mice indicates that the increased anxiety-like behaviors that followed adult deletion of Pet-1 were not due to deficiencies in Htr1a signaling. This result is consistent with the findings that although germline targeting of Htr1a leads to increased anxiety-related behaviors 39, 40 , reduced Htr1a signaling in adulthood does not 41 . These findings suggest that anxiety-like behavior in tamoxifen-treated Pet-1 aCKO mice may be caused by a different process than that responsible for increased anxiety in Pet-1 −/− mice. Nevertheless, our findings provide the first direct evidence in support of the concept that adult 5-HT-modulated behaviors are not hardwired during development but are transcriptionally regulated in the adult brain. Moreover, they highlight the potential importance of perturbations in serotonergic transcription at any stage of life in emotional pathogenesis.
Several characteristics of the expression and function of Pet-1 suggest that it is a terminal selector gene analogous to the Caenorhabditis elegans ETS terminal selector gene, ast-1, which coordinates the induction and maintenance of dopamine synthesis and transport in postmitotic neurons through a common conserved terminal selector motif 42 . Consistent with the fundamental properties of a terminal selector gene, Pet-1 is expressed throughout the life of postmitotic 5-HT neurons and is required not only to determine serotonergic identity but also to maintain it. However, like a terminal selector gene, it is not required for generic neuronal identity. Further key features of Pet-1 that fit with its classification as a terminal selector gene are that it directly regulates and maintains expression of terminal differentiation genes that define serotonergic-type identity and positively autoregulates its own expression, all through conserved ETS binding motifs 43 . It remains to be determined whether Pet-1 induces other transcription factors that then function cooperatively in a feedforward loop to control serotonergic identity.
Our findings raise the question of why Pet-1 is still needed in adult 5-HT neurons for regulation of a subset of its known embryonic targets but not for others such as Ddc, Slc18a2 and Htr1a. Expression of Tph2 and Slc6a4 in the adult is restricted to Pet-1-expressing 5-HT neurons and is rate-limiting for the essential serotonergic functions of 5-HT synthesis and reuptake. The expression of Tph2 and Slc6a4 in the adult DRN are regulated by external stimuli such as selective serotonin reuptake inhibitors and different stress paradigms 44, 45 . In addition, the expression of Tph2 and Slc6a4 in vivo are sensitive to the levels of Pet-1 expression 46 . We hypothesize ( Supplementary  Fig. 1 ) that environmentally induced alterations in the expression of Tph2 and Slc6a4 might be mediated through direct transcriptional activation by Pet-1, which itself is subject to extrinsic regulation 47 , thereby providing an efficient homeostatic transcriptional mechanism that acts throughout life to alter serotonergic function in response to environmental challenges.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureneuroscience/.
Note: Supplementary information is available on the Nature Neuroscience website.
